Ad is loading...
MGKCX
Price
$12.44
Change
-$0.07 (-0.56%)
Updated
Nov 15 closing price
RNPGX
Price
$64.77
Change
-$0.94 (-1.43%)
Updated
Nov 15 closing price
Ad is loading...

MGKCX vs RNPGX

Header iconMGKCX vs RNPGX Comparison
Open Charts MGKCX vs RNPGXBanner chart's image
Morgan Stanley Global Permanence C
Price$12.44
Change-$0.07 (-0.56%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R6
Price$64.77
Change-$0.94 (-1.43%)
VolumeN/A
CapitalizationN/A
MGKCX vs RNPGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGKCX vs. RNPGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGKCX is a StrongBuy and RNPGX is a StrongSell.

FUNDAMENTALS
Fundamentals
RNPGX has more cash in the bank: 142B vs. MGKCX (3.98M). RNPGX pays higher dividends than MGKCX: RNPGX (1.11) vs MGKCX (0.00). MGKCX was incepted earlier than RNPGX: MGKCX (6 years) vs RNPGX (16 years). MGKCX is a more actively managed with annual turnover of: 107.00 vs. RNPGX (17.00). RNPGX has a lower initial minimum investment than MGKCX: RNPGX (250) vs MGKCX (1000). RNPGX annual gain was more profitable for investors over the last year : 18.52 vs. MGKCX (8.84). RNPGX return over 5 years is better than : 40.54 vs. MGKCX (19.58).
MGKCXRNPGXMGKCX / RNPGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years16 years-
Gain YTD5.69215.80536%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.98M142B0%
Annual Yield % from dividends0.001.11-
Returns for 1 year8.8418.5248%
Returns for 3 years-22.26-9.39237%
Returns for 5 years19.5840.5448%
Returns for 10 yearsN/A69.74-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDI2.190.18
+8.96%
Calidi Biotherapeutics
EIX83.681.55
+1.89%
Edison International
ECPG49.220.83
+1.72%
Encore Capital Group
HWC58.45-0.96
-1.62%
Hancock Whitney Corp
ZNTL3.47-0.48
-12.15%
Zentalis Pharmaceuticals